US Stock MarketDetailed Quotes

ARVN Arvinas

Watchlist
  • 41.260
  • -0.070-0.17%
Trading Mar 28 13:57 ET
2.81BMarket Cap-6232P/E (TTM)

About Arvinas Company

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.

Company Profile

SymbolARVN
Company NameArvinas
Listing Date09/27/2018
Issue Price16.00
Founded2013
CEODr. John G. Houston, PhD
MarketNASDAQ
Employees445
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5 Science Park,395 Winchester Avenue
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06511
Phone1-203-535-1456

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John G. Houston, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 9.55M
  • Sean A. Cassidy
  • Chief Financial Officer and Treasurer
  • 3.51M
  • Dr. Ian Taylor, PhD
  • Chief Scientific Officer
  • 3.52M
  • Steve Weiss
  • Senior Vice President and Chief Human Resources Officer
  • --
  • Randy Teel, PhD
  • Interim Chief Financial Officer and Treasurer
  • --
  • David Loomis
  • Vice President and Chief Accounting Officer
  • --
  • Dr. Noah Berkowitz, M.D.
  • Chief Medical Officer
  • --
  • Dr. Wendy L. Dixon, PhD
  • Independent Director
  • 287.15K
  • John Douglas Young
  • Independent Director
  • 761.80K
  • Leslie V. Norwalk, Esq.
  • Independent Director
  • 291.47K
  • Everett V. Cunningham
  • Independent Director
  • 753.89K
  • Dr. Briggs W. Morrison, M.D.
  • Lead Independent Director
  • 291.69K
  • Linda C. Bain
  • Independent Director
  • 300.32K
  • Dr. Laurie Smaldone Alsup, M.D.
  • Independent Director
  • 288.97K
  • Dr. Sunil Agarwal, M.D.
  • Independent Director
  • --
  • Edward Kennedy, Jr
  • Independent Director
  • 287.15K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg